IgY-technology (egg yolk antibodies) in human medicine: a review of patents and clinical trials

IgY-technology (the production and extraction of specific IgY antibodies from egg yolk) is an innovative method to produce antibodies for therapy and prophylaxis. Advantages of IgY over other antibodies comprise its cost-effective extraction, the minimization of animal harm and distress, and its red...

Descripción completa

Detalles Bibliográficos
Autores principales: Leiva, Carlos, Gallardo, Mauro Julián, Casanova, Natalia Andrea, Terzolo, Horacio, Chacana, Pablo
Formato: Artículo
Lenguaje:Inglés
Publicado: Elsevier 2020
Materias:
Acceso en línea:http://hdl.handle.net/20.500.12123/6713
https://www.sciencedirect.com/science/article/pii/S1567576919323677
https://doi.org/10.1016/j.intimp.2020.106269
_version_ 1855483867465515008
author Leiva, Carlos
Gallardo, Mauro Julián
Casanova, Natalia Andrea
Terzolo, Horacio
Chacana, Pablo
author_browse Casanova, Natalia Andrea
Chacana, Pablo
Gallardo, Mauro Julián
Leiva, Carlos
Terzolo, Horacio
author_facet Leiva, Carlos
Gallardo, Mauro Julián
Casanova, Natalia Andrea
Terzolo, Horacio
Chacana, Pablo
author_sort Leiva, Carlos
collection INTA Digital
description IgY-technology (the production and extraction of specific IgY antibodies from egg yolk) is an innovative method to produce antibodies for therapy and prophylaxis. Advantages of IgY over other antibodies comprise its cost-effective extraction, the minimization of animal harm and distress, and its reduced reactivity with mammalian factors. Many research groups have demonstrated that IgY is active against several pathogens or conditions, a fact that may support the design of novel, safe and effective health products. This review provides a comprehensive analysis of IgY-based biologicals for human medicine, including patent applications and clinical trials during the period 2010–2018, and addresses how IgY-technology can lead to innovation in the production of biologicals for the treatment and prophylaxis of a wide range of infectious and non-communicable diseases.
format Artículo
id INTA6713
institution Instituto Nacional de Tecnología Agropecuaria (INTA -Argentina)
language Inglés
publishDate 2020
publishDateRange 2020
publishDateSort 2020
publisher Elsevier
publisherStr Elsevier
record_format dspace
spelling INTA67132023-01-13T13:59:26Z IgY-technology (egg yolk antibodies) in human medicine: a review of patents and clinical trials Leiva, Carlos Gallardo, Mauro Julián Casanova, Natalia Andrea Terzolo, Horacio Chacana, Pablo Antibodies Egg Yolk Therapy Patents Clinical Trials Medical Sciences Human Diseases Anticuerpos Yema de Huevo Terapia Patentes Ensayos Clínicos Ciencias Médicas Enfermedades Humanas IgY Antibody Anticuerpo IgY IgY-technology (the production and extraction of specific IgY antibodies from egg yolk) is an innovative method to produce antibodies for therapy and prophylaxis. Advantages of IgY over other antibodies comprise its cost-effective extraction, the minimization of animal harm and distress, and its reduced reactivity with mammalian factors. Many research groups have demonstrated that IgY is active against several pathogens or conditions, a fact that may support the design of novel, safe and effective health products. This review provides a comprehensive analysis of IgY-based biologicals for human medicine, including patent applications and clinical trials during the period 2010–2018, and addresses how IgY-technology can lead to innovation in the production of biologicals for the treatment and prophylaxis of a wide range of infectious and non-communicable diseases. Instituto de Patobiología Fil: Leiva, Carlos. Instituto Nacional de Tecnología Agropecuaria (INTA). Instituto de Patobiología; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina Fil: Gallardo, Mauro Julián. Instituto Nacional de Tecnología Agropecuaria (INTA). Instituto de Patobiología; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina Fil: Casanova, Natalia Andrea. Instituto Nacional de Tecnología Agropecuaria (INTA). Instituto de Patobiología; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina Fil: Terzolo, Horacio. Instituto Nacional de Tecnología Agropecuaria (INTA). Estación Experimental Agropecuaria Balcarce; Argentina Fil: Chacana, Pablo. Instituto Nacional de Tecnología Agropecuaria (INTA). Instituto de Patobiología; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina 2020-02-11T11:10:19Z 2020-02-11T11:10:19Z 2020-04 info:ar-repo/semantics/artículo info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://hdl.handle.net/20.500.12123/6713 https://www.sciencedirect.com/science/article/pii/S1567576919323677 1567-5769 https://doi.org/10.1016/j.intimp.2020.106269 eng info:eu-repo/semantics/restrictedAccess application/pdf Elsevier International Immunopharmacology 81 : 106269 (Abril 2020)
spellingShingle Antibodies
Egg Yolk
Therapy
Patents
Clinical Trials
Medical Sciences
Human Diseases
Anticuerpos
Yema de Huevo
Terapia
Patentes
Ensayos Clínicos
Ciencias Médicas
Enfermedades Humanas
IgY Antibody
Anticuerpo IgY
Leiva, Carlos
Gallardo, Mauro Julián
Casanova, Natalia Andrea
Terzolo, Horacio
Chacana, Pablo
IgY-technology (egg yolk antibodies) in human medicine: a review of patents and clinical trials
title IgY-technology (egg yolk antibodies) in human medicine: a review of patents and clinical trials
title_full IgY-technology (egg yolk antibodies) in human medicine: a review of patents and clinical trials
title_fullStr IgY-technology (egg yolk antibodies) in human medicine: a review of patents and clinical trials
title_full_unstemmed IgY-technology (egg yolk antibodies) in human medicine: a review of patents and clinical trials
title_short IgY-technology (egg yolk antibodies) in human medicine: a review of patents and clinical trials
title_sort igy technology egg yolk antibodies in human medicine a review of patents and clinical trials
topic Antibodies
Egg Yolk
Therapy
Patents
Clinical Trials
Medical Sciences
Human Diseases
Anticuerpos
Yema de Huevo
Terapia
Patentes
Ensayos Clínicos
Ciencias Médicas
Enfermedades Humanas
IgY Antibody
Anticuerpo IgY
url http://hdl.handle.net/20.500.12123/6713
https://www.sciencedirect.com/science/article/pii/S1567576919323677
https://doi.org/10.1016/j.intimp.2020.106269
work_keys_str_mv AT leivacarlos igytechnologyeggyolkantibodiesinhumanmedicineareviewofpatentsandclinicaltrials
AT gallardomaurojulian igytechnologyeggyolkantibodiesinhumanmedicineareviewofpatentsandclinicaltrials
AT casanovanataliaandrea igytechnologyeggyolkantibodiesinhumanmedicineareviewofpatentsandclinicaltrials
AT terzolohoracio igytechnologyeggyolkantibodiesinhumanmedicineareviewofpatentsandclinicaltrials
AT chacanapablo igytechnologyeggyolkantibodiesinhumanmedicineareviewofpatentsandclinicaltrials